Omnicare pays $124 million for improper inducements to nursing homes whistleblowers get $25 million

Omnicare is the nation’s largest provider of pharmaceuticals and pharmacy services to nursing homes and it is paying over $124 million for offering improper financial incentives to skilled nursing homes in return for their selecting Omnicare to supply their drugs to elderly Medicare and Medicaid patients.

The complaint alleged that Omnicare submitted false claims by entering into below-cost cntracts to supply prescription medications to skilled nursing facilities. The anti-kickback statute prohibits offering, paying, soliciting, or receiving remuneration to induce referrals or items or services covered by Medicare, Medicaid and other federally funded programs.

Jeffrey Newman represents whistleblowers.